Diagnostic and Pathophysiological Impact of FP-CIT SPECT in Parkinson 's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|7|3|173-176

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.7, Iss.3, 2007-01, pp. : 173-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utilization of the DaT-SCAN SPECT in the Diagnosis of Parkinson's Disease in Older Subjects

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 8, 2015-10 ,pp. : 614-621

Bentham Science Publishers

Access to resources Recommend Favorite

PET and SPECT Radiotracers for Alzheimer’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 28, 2015-01 ,pp. : 3278-3304

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1083-1085

Bentham Science Publishers

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl   Henchcliffe Claire  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Dopaminergic substitution in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite